The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients
Blood Sci
.
2023 Sep 8;5(4):277-279.
doi: 10.1097/BS9.0000000000000171.
eCollection 2023 Oct.
Author
Defu Zeng
1
2
Affiliations
1
Authur D. Riggs Diabetes and Metabolism Research Institute, The Beckman Research Institute of City of Hope, Duarte, CA.
2
Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA.
PMID:
37941918
PMCID:
PMC10629734
DOI:
10.1097/BS9.0000000000000171
No abstract available
Grants and funding
R01 HL162847/HL/NHLBI NIH HHS/United States